These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30573962)

  • 1. Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade.
    Luo J; Chen S; Min S; Peng L
    Ther Clin Risk Manag; 2018; 14():2397-2406. PubMed ID: 30573962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.
    Thilen SR; Ng IC; Cain KC; Treggiari MM; Bhananker SM
    Br J Anaesth; 2018 Aug; 121(2):367-377. PubMed ID: 30032875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children.
    Gaver RS; Brenn BR; Gartley A; Donahue BS
    Anesth Analg; 2019 Oct; 129(4):1124-1129. PubMed ID: 31584918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual neuromuscular blockade in the postanesthesia care unit: observational cross-sectional study of a multicenter cohort.
    Errando CL; Garutti I; Mazzinari G; Díaz-Cambronero Ó; Bebawy JF;
    Minerva Anestesiol; 2016 Dec; 82(12):1267-1277. PubMed ID: 27232277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
    de Boer HD; Carlos RV; Brull SJ
    BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of sugammadex for reversal of neuromuscular block.
    Honing G; Martini CH; Bom A; van Velzen M; Niesters M; Aarts L; Dahan A; Boon M
    Expert Opin Drug Saf; 2019 Oct; 18(10):883-891. PubMed ID: 31359807
    [No Abstract]   [Full Text] [Related]  

  • 17. Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review.
    Tajaate N; Schreiber JU; Fuchs-Buder T; Jelting Y; Kranke P
    Eur J Anaesthesiol; 2018 Mar; 35(3):184-192. PubMed ID: 29189420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrio-ventricular Block Following Neostigmine-Glycopyrrolate Reversal in Non-heart Transplant Patients: Case Report.
    Nkemngu NJ; Tochie JN
    Anesth Prog; 2018; 65(3):187-191. PubMed ID: 30235426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.